Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

West Pharmaceutical Services (WST)

West Pharmaceutical Services (WST)
208.61 x 100 233.50 x 100
Post-market by (Cboe BZX)
226.06 +1.15 (+0.51%) 03/27/25 [NYSE]
208.61 x 100 233.50 x 100
Post-market 226.06 unch (unch) 16:06 ET
Quote Overview for Thu, Mar 27th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
223.02
Day High
227.57
Open 225.32
Previous Close 224.91 224.91
Volume 562,100 562,100
Avg Vol 1,023,375 1,023,375
Stochastic %K 31.99% 31.99%
Weighted Alpha -31.36 -31.36
5-Day Change -1.45 (-0.64%) -1.45 (-0.64%)
52-Week Range 197.01 - 397.72 197.01 - 397.72
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,259,418
  • Shares Outstanding, K 72,293
  • Annual Sales, $ 2,893 M
  • Annual Income, $ 492,700 K
  • EBIT $ 570 M
  • EBITDA $ 725 M
  • 60-Month Beta 1.09
  • Price/Sales 5.64
  • Price/Cash Flow 25.06
  • Price/Book 6.10

Options Overview Details

View History
  • Implied Volatility 36.98% ( -1.91%)
  • Historical Volatility 143.74%
  • IV Percentile 71%
  • IV Rank 41.09%
  • IV High 56.00% on 02/10/25
  • IV Low 23.71% on 05/17/24
  • Put/Call Vol Ratio 0.82
  • Today's Volume 60
  • Volume Avg (30-Day) 292
  • Put/Call OI Ratio 0.50
  • Today's Open Interest 9,457
  • Open Int (30-Day) 10,374

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.30
  • Number of Estimates 5
  • High Estimate 1.59
  • Low Estimate 1.21
  • Prior Year 1.56
  • Growth Rate Est. (year over year) -16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
220.53 +2.51%
on 03/13/25
Period Open: 222.56
236.71 -4.50%
on 03/07/25
+3.50 (+1.57%)
since 02/27/25
3-Month
197.01 +14.75%
on 02/13/25
Period Open: 333.22
348.90 -35.21%
on 01/28/25
-107.16 (-32.16%)
since 12/27/24
52-Week
197.01 +14.75%
on 02/13/25
Period Open: 394.10
397.72 -43.16%
on 03/28/24
-168.04 (-42.64%)
since 03/27/24

Most Recent Stories

More News
Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks

Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks

FTRE : 8.36 (-1.07%)
UFPT : 203.23 (-0.15%)
AZTA : 35.52 (-2.44%)
WST : 226.06 (+0.51%)
IQV : 179.36 (-0.37%)
Is West Pharmaceutical Services Stock Underperforming the S&P 500?

West Pharmaceutical Services has lagged behind the broader S&P 500 Index over the past year, but analysts remain highly optimistic about its future growth potential.

$SPX : 5,693.31 (-0.33%)
RMD : 222.62 (+0.33%)
WST : 226.06 (+0.51%)
Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

FTRE : 8.36 (-1.07%)
MEDP : 316.61 (-0.33%)
AZTA : 35.52 (-2.44%)
WST : 226.06 (+0.51%)
IQV : 179.36 (-0.37%)
Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks

Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks

FTRE : 8.36 (-1.07%)
UFPT : 203.23 (-0.15%)
AZTA : 35.52 (-2.44%)
WST : 226.06 (+0.51%)
CRL : 158.06 (-0.12%)
3 Top-Rated Dividend Aristocrats to Buy Now for Passive Income

These three companies have increased their dividends for 25-plus years and offer a mix of stability, growth potential, and attractive yields.

KO : 70.74 (+1.03%)
$SPX : 5,693.31 (-0.33%)
SPGI : 508.64 (+0.17%)
WST : 226.06 (+0.51%)
Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks

Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks

FTRE : 8.36 (-1.07%)
UFPT : 203.23 (-0.15%)
AZTA : 35.52 (-2.44%)
RGEN : 137.12 (-1.66%)
WST : 226.06 (+0.51%)
Do Wall Street Analysts Like West Pharmaceutical Services Stock?

West Pharmaceutical Services has trailed behind the broader market over the past year, yet analysts remain highly optimistic, standing by its potential for a strong rebound.

$SPX : 5,693.31 (-0.33%)
WST : 226.06 (+0.51%)
MDEV : 20.34 (+0.44%)
S&P Futures Tick Lower With U.S. Retail Sales Data in Focus

March S&P 500 E-Mini futures (ESH25) are trending down -0.15% this morning, taking a breather at the end of a turbulent week, while investors await a raft of U.S. economic data, with a particular focus...

APP : 261.70 (-20.12%)
AMAT : 147.68 (-1.99%)
ROKU : 76.05 (-2.34%)
TTD : 57.26 (-2.62%)
MU : 91.16 (-1.05%)
ABNB : 125.65 (-2.32%)
ESH25 : 5,617.80s (-0.79%)
TOM.O.DX : 157.050 (-1.04%)
DVA : 152.50 (+0.75%)
RMS.FP : 2,474.000 (+0.08%)
MGM : 31.61 (-1.59%)
INTC : 23.62 (+0.85%)
Stocks Rally as Inflation Fears Recede and Tariffs Delayed

The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +1.04%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.77%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.43%. March E-mini S&P...

AMAT : 147.68 (-1.99%)
APP : 261.70 (-20.12%)
DE : 479.72 (-0.81%)
TAP : 60.96 (+0.66%)
CSCO : 61.40 (-0.65%)
TTD : 57.26 (-2.62%)
ADI : 208.94 (-0.76%)
DDOG : 104.85 (-2.89%)
KHC : 30.07 (+1.28%)
$IUXX : 19,798.62 (-0.59%)
ASML : 690.63 (-2.14%)
ZNM25 : 110-175 (+0.11%)
Why West Pharmaceutical Services (WST) Stock Is Nosediving

Why West Pharmaceutical Services (WST) Stock Is Nosediving

WST : 226.06 (+0.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical...

See More

Key Turning Points

3rd Resistance Point 232.63
2nd Resistance Point 230.10
1st Resistance Point 228.08
Last Price 226.06
1st Support Level 223.53
2nd Support Level 221.00
3rd Support Level 218.98

See More

52-Week High 397.72
Fibonacci 61.8% 321.05
Fibonacci 50% 297.36
Fibonacci 38.2% 273.68
Last Price 226.06
52-Week Low 197.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies